News about Clinical Trials

BioXcel to develop drugs in oncology

BioXcel shapes entirely claimed auxiliary OnkosXcel to foster prescriptions centered in oncology

Clinical Trials | 21/04/2022 | By Sudeep Soparkar |  616

IDB therapies to improve with lymphoid cell maturity

New knowledge on lymphoid cell maturity could lead to more effective IBD therapies

Clinical Trials | 18/04/2022 | By Sudeep Soparkar |  548

Effects of rilzabrutinib in individuals with insusceptible thrombocytopenia

Positive phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine

Clinical Trials | 16/04/2022 | By Sudeep Soparkar |  664

Cryo-electron microscopy answers for help underlying science research

Thermo Fisher Scientific, the world innovator in serving science, as of late sent the cutting edge cryo-transmission electron magnifying lens at the Center for Cellular and Molecular Biology (CCMB), Hyderabad, Telangana. The office was inaugurated by Dr Shekhar Mande, chief general, Council of Scientific and Industrial Research (CSIR).

Clinical Trials | 13/04/2022 | By Sudeep Soparkar |  476

New Toolkit Supports Digital Endpoints in Drug Development

DiMe, Biogen, Eli Lilly, Pfizer, and other top pharma companies launched a toolkit to ensure that organizations develop digital endpoint evidence in an acceptable way during drug development.

Clinical Trials | 12/04/2022 | By Sudeep Soparkar |  401

To streamline submission of clinical trial applications for gene therapy, ICMR launches online portal

The GTAEC is an independent body of experts representing diverse areas of biomedical research, concerned government agencies and other stakeholders constituted and notified by the department of health research, Union ministry of health and family welfare to oversee the activities in the field of gene therapy research in India

Clinical Trials | 17/02/2022 | By Darshana |  443

Velocity Clinical Research announces three key tech investments for strengthening patient and client engagement in clinical trial

In the past 12 months, Velocity has randomized 25,000 patients into phase II and III studies in the US. The tech investments will enable Velocity to be more efficient in managing studies, identifying patients for studies, and increasing the frequency of participation in studies

Clinical Trials | 16/02/2022 | By Darshana |  297

Drug Technical Advisory Board suggests recommendations under clinical trial to DCGI

DTAB has recommended that the proposed provisions for grant of licence to manufacture and stock of new drug which is under clinical trial is considered appropriate for drugs/vaccines being developed for emergency/life-saving/COVID-19 and similar such conditions of public health importance

Clinical Trials | 14/02/2022 | By Darshana |  404

Serum's proposal to manufacture vaccine against omicron for test and analysis, gets a DGCI nod

The Drugs Controller General of India (DCGI) has approved Serum Institute of India?s proposal to manufacture a vaccine against omicron variant of coronavirus for examination, test and analysis.

Clinical Trials | 09/02/2022 | By Darshana |  170

Biotron announces its lead clinical asset, BIT225 effective against SARS-CoV-2 in animal and cell-based studies

Biotron Limited, a company engaged in the research, development, and commercialisation of drugs targeting significant viral diseases with unmet medical need, announced that the company?s lead clinical asset, BIT225, has demonstrated substantial and clinically meaningful efficacy against SARS-CoV-2 in a series of animal and cell-based studies performed

Clinical Trials | 29/11/2021 | By Darshana |  190